Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Similar content being viewed by others Subjects Main Non-competitive, open-channel NMDA receptor blockers are used clinically for the management of Alzheimers disease and treatment-resistant depression 2,3
Am J Physiol-Regul Integr Comp Physiol (2016) 310:R88595
Compared to the native hormones, retatrutide shows 2.9-fold less potency at the glucagon receptor (GCCR), 2.5-fold less potency at the GLP-1 receptor, and 8.9-fold greater potency at human GIP receptor [1]
Zepbound targets two hormone receptors (GLP-1 and GIP), while Wegovy targets just one, which is part of why the two medications don't always produce identical results
This matters because what a medicine is officially approved for shapes the highest dose a doctor can prescribe, the rules that apply to it, and whether UAE insurers will pay for it (see our common myths about weight loss injections for a fuller breakdown)
This is when changes in body measurements become more apparent, and patients may need to adjust clothing sizes
